OPEN END TURBO SHORT - RESMED | Real-time Bid/Ask 07:47:51 2024-06-20 EDT | ||
| 1.39 EUR / 1.64 EUR | +21.20% |
|
| Current month | -29.38% | ||
| 1 month | +86.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 1.27 | +1.60% |
| 24-06-19 | 1.25 | +1.63% |
| 24-06-18 | 1.23 | -13.99% |
| 24-06-17 | 1.43 | +7.52% |
| 24-06-14 | 1.33 | +9.02% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 02:53 am
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG3BR6 |
| ISIN | DE000MG3BR69 |
| Date issued | 2024-04-30 |
| Strike | 224.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.65 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.84 € |
|---|---|
| Lowest since issue | 0.47 € |
| Spread | 0.25 € |
| Spread % | 15.34% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
212.3
USD
Average target price
203.6
USD
Spread / Average Target
-4.10%
- Stock Market
- Certificates
- Certificat
